AHA Coding Clinic® for HCPCS - 2012 Issue 1; FOR your INFORMATION
New HCPCS Codes and Dosage Descriptors for Certain Drugs, Biologicals, and Radiopharmaceuticals
Effective for January 1, 2012, the Centers for Medicare & Medicaid Services (CMS) created several new HCPCS codes for the reporting of drugs and biologicals in the hospital outpatient setting. The new codes are listed below: New CY 2012 HCPCS codes for Certain Drugs, Biologicals, and Radiopharmaceuticals CY 2012 HCPCS Code CY 2012 Long Descriptor A9585 Injection gadobutrol, 0.1 ml C9287 Injection, brentuximab vedotin, 1 mg C9366 EpiFix, per square centimeter J0257 Injection, alpha 1 proteinase inhibitor (human), (glassia), 10 mg J7180 Injection, factor xiii (antihemophilic factor, human), 1 i.u. J7326 Hyaluronan or derivative, gel-one, for...
Subscribe or sign in to view the full article.
Article Overview
This CMS-focused article explains calendar year 2012 HCPCS updates for selected hospital outpatient drugs, biologicals, and radiopharmaceuticals. It is useful for coding, billing, and reimbursement professionals who need to track newly created HCPCS identifiers, code descriptor revisions, and effective-date changes affecting outpatient drug reporting.
Why This Topic Matters
HCPCS updates can affect how hospitals and other providers report drugs and biologics in outpatient claims. Understanding the annual changes helps coding teams stay aligned with CMS reporting updates and maintain accurate charge capture and claim submission workflows.
Article Sections
-
New CY 2012 HCPCS codes for certain drugs, biologicals, and radiopharmaceuticals
This section presents the new HCPCS identifiers created for calendar year 2012 and the general types of products they cover. It is a reference list for outpatient drug and biologic reporting updates.
-
CY 2011 to CY 2012 HCPCS code descriptor changes
This section summarizes selected HCPCS descriptor changes between calendar year 2011 and calendar year 2012. It includes crosswalk-style updates and notes on revised effective dates for certain entries.
-
Footnotes
This section provides explanatory notes tied to specific HCPCS entries and effective-date adjustments. It clarifies background for a few of the listed code changes without expanding into broader guidance.
What You Will Learn
- How CMS updated HCPCS reporting for certain outpatient drugs and biologics for calendar year 2012
- Which kinds of HCPCS changes were introduced or revised during the update cycle
- How effective dates and code crosswalks are presented in the article
- Which product categories are represented in the annual HCPCS update list
Who Should Read This
- Hospital outpatient coders
- Billing and reimbursement staff
- Revenue cycle professionals
- Compliance teams
- Drug and biologic charge capture staff
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com